COMMUNIQUÉS West-GlobeNewswire

-
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
09/07/2018 -
Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial
09/07/2018 -
Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma
09/07/2018 -
National Lipid Association Announces Recipients of 2018-19 Junior Faculty Research Awards
06/07/2018 -
John Inadomi, MD is Honored by the American Health Council for “Best in Medicine”
06/07/2018 -
Abiomed First Quarter Fiscal 2019 Earnings And Conference Call Notification
06/07/2018 -
Barbara Nye, MD is Appointed to the American Health Council’s Board of Physicians
06/07/2018 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2018
06/07/2018 -
Tauriga Sciences Inc. Receives Confirmation from FINRA that its Reverse Split will take Effect at Open of Trading Monday July 9, 2018; the Company’s Ticker Symbol will be Amended to “TAUGD” for a Period of 20 Business Days
06/07/2018 -
AC Immune Announces Results of Annual General Meeting
06/07/2018 -
Major shareholder announcement
06/07/2018 -
Auxly Announces Upgrade on OTC Markets to OTCQX
06/07/2018 -
Cannabis Act Regulations Indicative of Radient Technologies’ Role in Industrial-Scale Cannabis and Hemp Value Chains
06/07/2018 -
RAMSAY GENERALE DE SANTE : Financement - Fiducie sûreté
06/07/2018 -
Orion has started a Phase III trial to develop a drug for ALS - The patient recruitment has begun
06/07/2018 -
CellaVision AB presents the second quarter 2018 on July 17 at 11:00 CET
06/07/2018 -
Herantis Pharma initiates non-invasive CDNF development program, announces licensing agreement with University of Helsinki
06/07/2018 -
ObsEva SA Shares to Begin Trading on SIX Swiss Exchange
06/07/2018 -
Takeda and TiGenix Announce Results of Second Acceptance Period for the Voluntary and Conditional Public Takeover Bid
06/07/2018
Pages